Abstract No. 440 Multimodality therapy improves survival in hepatocellular carcinoma patients with cirrhosis: a propensity score matching analysis

To evaluate and compare survival in nontransplant hepatocellular carcinoma (HCC) patients who received multimodality therapy (MMT) and single modality therapy (SMT). IRB-approved retrospective review of 583 cirrhotic patients who received locoregional therapy (LRT) for HCC without liver transplantation from 2000 to 2017. Patients who had surgery (n = 36), chemotherapy (n = 119) and radiotherapy (n = 46) in addition to LRT were excluded. Patients...